4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL
Atefeh Garzan, S. Kaleem Ahmed, Nicole N. Haese, Gauthami Sulgey, Samuel Medica, Jessica L. Smith, Sixue Zhang, Fahim Ahmad, Shuklendu Karyakarte, Lynn Rasmussen, Victor DeFilippis, Babu Tekwani, Robert Bostwick, Mark J. Suto, Alec J. Hirsch, Thomas E. Morrison, Mark T. Heise, Corinne E. Augelli-Szafran, Daniel N. Streblow, Ashish K. Pathak and Omar Moukha-Chafiq*, 
{"title":"4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses","authors":"Atefeh Garzan,&nbsp;S. Kaleem Ahmed,&nbsp;Nicole N. Haese,&nbsp;Gauthami Sulgey,&nbsp;Samuel Medica,&nbsp;Jessica L. Smith,&nbsp;Sixue Zhang,&nbsp;Fahim Ahmad,&nbsp;Shuklendu Karyakarte,&nbsp;Lynn Rasmussen,&nbsp;Victor DeFilippis,&nbsp;Babu Tekwani,&nbsp;Robert Bostwick,&nbsp;Mark J. Suto,&nbsp;Alec J. Hirsch,&nbsp;Thomas E. Morrison,&nbsp;Mark T. Heise,&nbsp;Corinne E. Augelli-Szafran,&nbsp;Daniel N. Streblow,&nbsp;Ashish K. Pathak and Omar Moukha-Chafiq*,&nbsp;","doi":"10.1021/acs.jmedchem.4c0107310.1021/acs.jmedchem.4c01073","DOIUrl":null,"url":null,"abstract":"<p >2-(Methylthio)-<i>N</i>-(4-(naphthalen-2-yl)thiazol-2-yl)nicotinamide <b>1</b> was identified as an inhibitor against Chikungunya virus (CHIKV) with good antiviral activity [EC<sub>50</sub> = 0.6 μM; EC<sub>90</sub> = 0.93 μM and viral titer reduction (VTR) of 6.9 logs at 10 μM concentration] with no observed cytotoxicity (CC<sub>50</sub> = 132 μM) in normal human dermal fibroblast (NHDF) cells. Structure–activity relationship (SAR) studies to further improve the potency, efficacy, and drug-like properties of <b>1</b> led to the discovery of a new potent inhibitor <i>N</i>-(4-(3-((4-cyanophenyl)amino)phenyl)thiazol-2-yl)-2-(methylthio)nicotinamide <b>26</b>, which showed a VTR of 8.7 logs at 10 μM against CHIKV and an EC<sub>90</sub> of 0.45 μM with considerably improved MLM stability (<i>t</i><sub>1/2</sub> = 74 min) as compared to <b>1</b>. Mechanism of action studies show that <b>26</b> inhibits alphavirus replication by blocking subgenomic viral RNA translation and structural protein synthesis. The <i>in vivo</i> efficacy studies of compound <b>26</b> on CHIKV infection in mice are reported.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"67 23","pages":"20858–20878 20858–20878"},"PeriodicalIF":6.8000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01073","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

2-(Methylthio)-N-(4-(naphthalen-2-yl)thiazol-2-yl)nicotinamide 1 was identified as an inhibitor against Chikungunya virus (CHIKV) with good antiviral activity [EC50 = 0.6 μM; EC90 = 0.93 μM and viral titer reduction (VTR) of 6.9 logs at 10 μM concentration] with no observed cytotoxicity (CC50 = 132 μM) in normal human dermal fibroblast (NHDF) cells. Structure–activity relationship (SAR) studies to further improve the potency, efficacy, and drug-like properties of 1 led to the discovery of a new potent inhibitor N-(4-(3-((4-cyanophenyl)amino)phenyl)thiazol-2-yl)-2-(methylthio)nicotinamide 26, which showed a VTR of 8.7 logs at 10 μM against CHIKV and an EC90 of 0.45 μM with considerably improved MLM stability (t1/2 = 74 min) as compared to 1. Mechanism of action studies show that 26 inhibits alphavirus replication by blocking subgenomic viral RNA translation and structural protein synthesis. The in vivo efficacy studies of compound 26 on CHIKV infection in mice are reported.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信